These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31919862)

  • 1. Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
    Farrow NE; Freischlag KW; Adam MA; Blazer DG
    J Surg Oncol; 2020 Mar; 121(3):486-493. PubMed ID: 31919862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival.
    Leung K; Sun Z; Nussbaum DP; Adam MA; Worni M; Blazer DG
    Surg Oncol; 2017 Sep; 26(3):324-330. PubMed ID: 28807254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total gastrectomy in patients with gastric adenocarcinoma: Is there an advantage to the minimally invasive approach?
    Sweigert PJ; Eguia E; Nelson MH; Nassoiy SP; Knab LM; Abood G; Baker MS
    Surgery; 2019 Oct; 166(4):623-631. PubMed ID: 31326190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China.
    Lu J; Yoon C; Xu B; Xie J; Li P; Zheng C; Huang C; Yoon SS
    Ann Surg Oncol; 2020 Mar; 27(3):802-811. PubMed ID: 31894481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.
    Chen L; Zhang C; Yao Z; Cui M; Xing J; Yang H; Zhang N; Liu M; Xu K; Tan F; Li Y; Jiang B; Su X
    BMC Cancer; 2021 Aug; 21(1):974. PubMed ID: 34461860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of minimally invasive surgery for early gastric cancer are comparable with those for open surgery: analysis of 1,013 minimally invasive surgeries at a single institution.
    Oh SY; Kwon S; Lee KG; Suh YS; Choe HN; Kong SH; Lee HJ; Kim WH; Yang HK
    Surg Endosc; 2014 Mar; 28(3):789-95. PubMed ID: 24263458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 8. Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes.
    Bischof DA; Kim Y; Dodson R; Carolina Jimenez M; Behman R; Cocieru A; Blazer DG; Fisher SB; Squires MH; Kooby DA; Maithel SK; Groeschl RT; Clark Gamblin T; Bauer TW; Karanicolas PJ; Law C; Quereshy FA; Pawlik TM
    Ann Surg Oncol; 2014 Sep; 21(9):2941-8. PubMed ID: 24763984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
    Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.
    Ecker BL; Datta J; McMillan MT; Poe SL; Drebin JA; Fraker DL; Dempsey DT; Karakousis GC; Roses RE
    J Surg Oncol; 2015 Nov; 112(6):616-21. PubMed ID: 26394810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of gastrectomy for gastric cancer among octogenarians: a western population-based study.
    Pak LM; Yang T; Wang J
    J Geriatr Oncol; 2019 Jul; 10(4):598-603. PubMed ID: 30366851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study.
    Caruso S; Patriti A; Marrelli D; Ceccarelli G; Ceribelli C; Roviello F; Casciola L
    Int J Med Robot; 2011 Dec; 7(4):452-8. PubMed ID: 21984205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive surgery for remnant gastric cancer: a comparison with open surgery.
    Kwon IG; Cho I; Guner A; Choi YY; Shin HB; Kim HI; An JY; Cheong JH; Noh SH; Hyung WJ
    Surg Endosc; 2014 Aug; 28(8):2452-8. PubMed ID: 24622766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborative.
    Spolverato G; Kim Y; Ejaz A; Valero V; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Acher AW; Votanopoulos K; Schmidt C; Cho CS; Maithel SK; Pawlik TM
    J Gastrointest Surg; 2014 Sep; 18(9):1563-74. PubMed ID: 24912915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive surgery as a treatment option for gastric cancer in the elderly: comparison with open surgery for patients 80 years and older.
    Kwon IG; Cho I; Guner A; Kim HI; Noh SH; Hyung WJ
    Surg Endosc; 2015 Aug; 29(8):2321-30. PubMed ID: 25480603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive surgery for gastric cancer: the American experience.
    Greenleaf EK; Sun SX; Hollenbeak CS; Wong J
    Gastric Cancer; 2017 Mar; 20(2):368-378. PubMed ID: 26961133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
    Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
    Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.